Callahan Advisors’s Ernexa Therapeutics ERNA Stock Holding History
Bought
Maintained
Sold
Other funds holding ERNA
Callahan Advisors's ERNA Position: Q1 2020 in Review
Callahan Advisors sold out of Ernexa Therapeutics (ERNA) in Q1 2020, closing a stake of 1 share — an estimated $41K sold.
Callahan Advisors first reported a position in ERNA in Q4 2016 and held it in 13 quarters. The position peaked at $162K in Q1 2017. 7 funds tracked by Wall St. Rank hold ERNA as of Q1 2020.
- Callahan Advisors reported no remaining Ernexa Therapeutics position as of Q1 2020 after selling out during the quarter.
- Callahan Advisors sold 1 Ernexa Therapeutics share in Q1 2020, an estimated $41K.
- Callahan Advisors first reported a position in Ernexa Therapeutics in Q4 2016 and held it in 13 quarters.
- Callahan Advisors's Ernexa Therapeutics position peaked at $162K in Q1 2017.
- 7 funds tracked by Wall St. Rank held Ernexa Therapeutics as of Q1 2020.
Based on Callahan Advisors's 13F filing for Q1 2020, filed 6 Apr 2020.